It is no secret that advertising litigation involving FDA-regulated products has been on the uptick in recent years. What is less known is that there have been significant developments in case law that may help advertisers obtain coverage for their advertising-related litigation expenses.
Originally published in Update Magazine - March/April 2018.
Please see full publication below for more information.
